A Pivotal Moment for Cell and Gene Therapies: Experts Reflect on Setbacks and Offer Guidance for the Road Ahead
After years of scientific advances and ramped-up investment in cell and gene therapies, enthusiasm in the field has been tempered on the heels of high-profile setbacks. But the clinical promise of these therapies is undeniable.
Where will the industry go from here? Don't miss Fierce’s virtual event this November for an up-to-date, realistic look at the field of advanced therapies.
Discover the Future of Cell & Gene Therapies—From Regulatory Shifts to Real-World Impact
- Gain firsthand insights from FDA leaders, investors, and biotech executives shaping the future of cell and gene therapies.
- Discover strategies to overcome commercialization hurdles, from approval through patient access.
- Get a realistic pulse on the funding landscape and where opportunities still exist for advanced therapies.
- Stay ahead with expert analysis of recent setbacks and what they mean for the road ahead.
- Enjoy flexible access to all sessions on-demand, so you never miss a critical discussion.
- Connect with peers and engage in live Q&A with leading voices across biotech and pharma.
Benefits of Attending
Audience Networking
Q&A
